Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03245151
Title Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.


Advanced Solid Tumor

high grade glioma

Ewing sarcoma


Everolimus + Lenvatinib

Age Groups: adult | child
Covered Countries USA | CAN

No variant requirements are available.